Compass Pathways Plc (CMPS)
11.69
+0.13
(+1.12%)
USD |
NASDAQ |
Oct 07, 16:00
11.75
+0.06
(+0.51%)
After-Hours: 07:46
Compass Pathways EPS Diluted (Quarterly) : -1.883 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.883 |
| March 31, 2026 | -0.3044 |
| December 31, 2025 | -1.001 |
| September 30, 2025 | -1.436 |
| June 30, 2025 | -0.4165 |
| March 31, 2025 | -0.2011 |
| December 31, 2024 | -0.627 |
| September 30, 2024 | -0.5687 |
| June 30, 2024 | -0.5579 |
| March 31, 2024 | -0.5476 |
| December 31, 2023 | -0.5296 |
| September 30, 2023 | -0.6688 |
| June 30, 2023 | -0.6238 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.5717 |
| December 31, 2022 | -0.7309 |
| September 30, 2022 | -0.4283 |
| June 30, 2022 | -0.491 |
| March 31, 2022 | -0.5007 |
| December 31, 2021 | -0.6112 |
| September 30, 2021 | -0.3783 |
| June 30, 2021 | -0.4391 |
| March 31, 2021 | -0.3512 |
| December 31, 2020 | -0.5279 |
| September 30, 2020 | -0.4646 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.9306 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.0866 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.007 |
| Mereo BioPharma Group Plc | -0.0437 |
| HemoGenyx Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -254.25M |
| Total Expenses (Quarterly) | 254.25M |
| Enterprise Value | 1.208B |
| Earnings Yield | -39.55% |
| Normalized Earnings Yield | -27.67 |